Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 12:10 AM
NCT ID:
NCT06734858
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 19 years or older
* Diagnosed with Post-Traumatic Stress Disorder (PTSD) or Adjustment Disorder (AD) according to the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)
* A score of 3 to 4 on the Clinical Global Impression-Severity (CGI-S) scale
* Able to access the internet and respond to app activity instructions
* Voluntarily decided to participate in this clinical trial and provided written consent by signing the participant information sheet and consent form
Exclusion Criteria:
* Those diagnosed with schizophrenia, bipolar disorder type 1, or psychotic disorders
* Those diagnosed with neurodevelopmental disorders, neurocognitive disorders, or organic mental disorders
* Those with severe depression (Patient Health Questionnaire-9 (PHQ-9) ≥ 20)
* Those with severe personality disorders
* Those diagnosed with substance use disorders (excluding nicotine and caffeine) or severe alcohol use disordes
* Those exhibiting active suicidal tendencies (suicidal thoughts, suicide attempts, or suicidal behavior)
* Those who have had a change in the type, dosage, or regimen of anxiolytics or antidepressants within 4 weeks of baseline
* Those currently participating in another clinical trial or who have participated in a clinical trial within 90 days prior to the screening visit
* Those deemed unsuitable for participation in the trial at the discretion of the investigator
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT06734858
Study Brief:
Protocol Section:
NCT06734858